Bronchogen
Bronchogen is a short synthetic tetrapeptide (Ala-Glu-Asp-Pro) developed within the Russian 'bioregulator' peptide research tradition associated with the St. Petersburg Institute of Bioregulation and Gerontology. It is promoted as a tissue-specific regulator intended to support bronchial and respiratory tissue function, and is primarily marketed and studied in Russia and neighboring countries rather than through Western regulatory pathways. Independent, large-scale clinical trial data outside this research group are limited, so claims about its effects should be treated as preliminary and unverified by major regulatory agencies such as the FDA or EMA. It is not an approved prescription drug in the United States or European Union and is best regarded as an emerging research compound.
Reported benefits
- Proposed support for bronchial and respiratory tissue function in preliminary Russian research
- Represents a short, simple peptide structure suggested to have a favorable safety profile in publications from its developers
- Used in some Eastern European clinical settings as an adjunct for respiratory conditions
How it works
Consistent with the proposed model for other short bioregulator peptides in this research line, Bronchogen is theorized to interact with gene regulatory regions to influence protein synthesis in bronchial and respiratory epithelial tissue, potentially supporting normal cellular turnover and function. As a short, unmodified tetrapeptide, it is expected to be rapidly degraded by peptidases once administered, and the precise molecular target and pharmacodynamics have not been established through independent, mechanistic studies.
Dosing ranges
| Tier | Dose | Frequency |
|---|---|---|
| Low | 50 mcg | once daily for a 10-day course |
| Moderate | 100 mcg | once daily for a 10-day course |
| High | 200 mcg | once daily for a 10-day course |
Estimate your dose
Dose estimator
Educational estimate for Bronchogen, scaled to body size. Not medical advice.
Read before using
This tool produces a rough, educational estimate by scaling commonly-published research ranges to lean body mass. It is not a prescription, medical advice, or a substitute for a licensed clinician. Most peptides use fixed dosing, not weight-based dosing. Individual needs vary. You are solely responsible for how you use this information.
Mixing & syringe units
Target dose follows the estimate above. Change it there, or edit it directly below.
Reconstitution calculator
How much water to add and how many insulin-syringe units to draw for Bronchogen. Educational only.
Draw to this mark
2units
= 0.02 mL for a 100 mcg dose
Concentration
5,000 mcg/mL
Doses per vial
100
A U-100 syringe reads 100 units per mL. This is a reconstitution math helper only, not a prescription or dosing advice. Verify every calculation and consult a qualified healthcare provider.
Possible side effects
Stacking notes
Sometimes combined with other tissue-specific bioregulator peptides from the same research line in published protocols; evidence supporting any additive benefit from combination is limited.
Common protocols
Common questions
What is Bronchogen used for?
Bronchogen is a short synthetic tetrapeptide (Ala-Glu-Asp-Pro) developed within the Russian 'bioregulator' peptide research tradition associated with the St. Petersburg Institute of Bioregulation and Gerontology. It is promoted as a tissue-specific regulator intended to support bronchial and respiratory tissue function, and is primarily marketed and studied in Russia and neighboring countries rather than through Western regulatory pathways. Independent, large-scale clinical trial data outside this research group are limited, so claims about its effects should be treated as preliminary and unverified by major regulatory agencies such as the FDA or EMA. It is not an approved prescription drug in the United States or European Union and is best regarded as an emerging research compound. Reported benefits include proposed support for bronchial and respiratory tissue function in preliminary russian research, represents a short, simple peptide structure suggested to have a favorable safety profile in publications from its developers, used in some eastern european clinical settings as an adjunct for respiratory conditions.
What is a typical Bronchogen dose?
Reported ranges run 50-200 mcg. A low protocol is 50 mcg once daily for a 10-day course, and a high protocol is 200 mcg once daily for a 10-day course. This is reference information, not a dosing recommendation.
What is the half life of Bronchogen?
Not well characterized; expected to be extremely short (on the order of minutes) given rapid proteolytic degradation typical of small, unprotected peptides. That is what sets the dosing frequency, and it is why the timing guidance is morning.
How is Bronchogen administered?
Subcutaneous: into fat, under the skin. Original research used subcutaneous injection; commercial products are more commonly sold as oral capsules, which have different absorption characteristics.
How long is a Bronchogen cycle?
Reported as a short course of about 10 days in published bioregulator protocols on, followed by Several months between courses, with courses sometimes repeated once or twice per year off. Based on Russian bioregulator peptide dosing conventions; these protocols have not been independently validated in large Western clinical trials.
What are the side effects of Bronchogen?
Reported side effects include limited independent safety data outside the originating research group, potential injection site reactions with parenteral use, theoretical risk of allergic response, as with any peptide product, effects and risks with long-term or repeated use are not well characterized. Evidence level for this compound is emerging research.
Partner offer · $20 off
When did you last
check your blood work?
Regular blood work catches changes early. At-home collection with free pickup, 50+ biomarkers, and results in 72 hours.
- 1Order your kitTakes two minutes online, $20 off with this link.
- 2Collect at homePainless draw with free home pickup, no lab visit.
- 3Results in 72 hours50+ biomarkers with clear optimal ranges.
Partner offer · opens rythm.health
Educational use only, not medical advice. This profile is provided for research and educational purposes. Bronchogen may be a research compound or a prescription medication; nothing here is intended to diagnose, treat, cure, or prevent any disease. Dosing figures reflect commonly-published research ranges, not a prescription. Consult a qualified healthcare provider before making any health decision. Read the full disclaimer →